We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




MRI-Related Patents Issued to Biophan

By MedImaging staff writers
Posted on 02 Sep 2005
Print article
Biophan Technologies, Inc. (Rochester, NY, USA) has two new U.S patents issued to the company, while one U.S. patent has been issued to Nanoset, LLC (East Rochester, NY, USA), a technology collaborator that has granted Biophan exclusive worldwide medical rights to the patent.

These newly issued patents increase Biophan's intellectual property portfolio to 144 U.S. patients, applications, or licenses. "These patents can provide improved capabilities to a wide variety of devices, increasing the technologies we have to offer,” said Michael Weiner, CEO of Biophan. "This fits with our strategy of providing enabling technology to many device manufacturers.”

One patent covers cardiac-assist devices designed to be compatible with magnetic resonance imaging (MRI), when MRI signals are detected, so that the communications circuit between the heart and the device can be interrupted, to avoid the possible hazards of tissue heating and induced voltages. Sensing the MRI unit's excitation signal by use of an opto-electronic device is covered by this patent. This is one of several approaches to address the problems of MRI safety and cardiac-assist devices such as defibrillators and pacemakers.

"In [another patent,] we teach how to convert electrical information, including radio waves, into optical signals to move them along an optical fiber, when used in conjunction with MRI,” Mr. Weiner added. "MRI provides the advantage of superior tissue imaging with no exposure to potentially harmful ionizing radiation. The technology also has potential applications for oncology, diabetes, and other diseases.”

The third patent covers almost any medical conductor, including a defibrillator, pacemaker, or neurostimulator lead, that includes nonmagnetic coatings and is designed to be flexible.

Biophan recently completed a licensing agreement and received an equity investment from Boston Scientific (Natick, MA, USA). Under the agreement, Boston Scientific receives specific licensing rights within certain product categories to these and other Biophan and Nanoset patents.



Related Links:
Biophan Technologies, Inc
New
Gold Member
X-Ray QA Meter
T3 AD Pro
Wall Fixtures
MRI SERIES
New
Multi-Use Ultrasound Table
Clinton
Ultrasound Color LCD
U156W

Print article
Radcal

Channels

Radiography

view channel
Image: The new X-ray detector produces a high-quality radiograph (Photo courtesy of ACS Central Science 2024, DOI: https://doi.org/10.1021/acscentsci.4c01296)

Highly Sensitive, Foldable Detector to Make X-Rays Safer

X-rays are widely used in diagnostic testing and industrial monitoring, from dental checkups to airport luggage scans. However, these high-energy rays emit ionizing radiation, which can pose risks after... Read more

MRI

view channel
Image: The scans revealed a new dimension of brain network organization in humans (Photo courtesy of Georgia State University/TReNDS Center Research)

New Approach Identifies Signatures of Chronic Brain Disorders Using fMRI Scans

Traditional studies of brain function, often using fMRI scans to detect brain activity patterns, have shown promise in identifying changes in individuals with chronic brain disorders like schizophrenia.... Read more

Nuclear Medicine

view channel
Image: Example of AI analysis of PET/CT images (Photo courtesy of Academic Radiology; DOI: 10.1016/j.acra.2024.08.043)

AI Analysis of PET/CT Images Predicts Side Effects of Immunotherapy in Lung Cancer

Immunotherapy has significantly advanced the treatment of primary lung cancer, but it can sometimes lead to a severe side effect known as interstitial lung disease. This condition is characterized by lung... Read more

General/Advanced Imaging

view channel
Image: Cleerly offers an AI-enabled CCTA solution for personalized, precise and measurable assessment of plaque, stenosis and ischemia (Photo courtesy of Cleerly)

AI-Enabled Plaque Assessments Help Cardiologists Identify High-Risk CAD Patients

Groundbreaking research has shown that a non-invasive, artificial intelligence (AI)-based analysis of cardiac computed tomography (CT) can predict severe heart-related events in patients exhibiting symptoms... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.